Annual report
2503.TEDINET S100QFXL
Period2022-01-01 → 2022-12-31
Filed2023-03-30
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.99T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.82T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.85T | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.94T | 2019-01-01 → 2019-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.93T | 2018-01-01 → 2018-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥116.0bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥68.1bn | 2021-01-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥191.4bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥99.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥124.5bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥116.8bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥246.9bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥111.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥59.8bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥71.9bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥59.6bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥164.2bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥143.8bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥68.4bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥2.54T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.47T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.46T | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.41T | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.30T | at 2018-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.29T | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.32T | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.25T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.15T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.10T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥980.0bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥894.2bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥838.6bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥906.6bn | at 2019-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥906.6bn | at 2018-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥88.1bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥149.5bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥161.7bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥165.7bn | at 2019-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥173.1bn | at 2018-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥135.6bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥219.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥164.8bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥178.8bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥198.1bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥10.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥56.4bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥116.0bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥175.6bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | ¥47.4bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥167.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥180.5bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥52.5bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥10.0bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥226.7bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥135.08 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥71.73 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥85.57 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥68 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥183.57 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥135.07 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥71.7 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥85.54 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥67.98 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥183.53 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥1,210.16 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,072.69 | at 2021-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,005.96 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,043.57 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥1,032.55 | at 2018-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 38.5% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 36.2% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 34.1% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.6% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 39.4% | at 2018-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 11.8% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.9% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.2% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.6% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 17.7% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 30,538 | at 2022-12-31 | Cons. | Number of employees |
| Revenue | ¥152.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥139.5bn | 2021-01-01 → 2021-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥138.8bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥138.6bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥106.8bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥74.6bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥74.3bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥76.9bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥73.8bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥72.0bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥77.7bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥95.7bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥76.0bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥75.1bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥48.7bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥77.3bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | ¥79.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥147.2bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥190.9bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.90T | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥2.00T | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥1.97T | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.95T | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.70T | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥947.7bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥989.7bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥951.1bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.01T | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥987.1bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥1.04T | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥981.5bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥17.4bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥21.4bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥59.24 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥92.67 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥94.37 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.87 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.39 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥69 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65 | 2021-01-01 → 2021-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥65 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥64 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥51 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,174.47 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,208.06 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,184.06 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,199.12 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,117.87 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 50.1% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.4% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.5% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.0% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.8% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 914,000,000 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 914,000,000 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 914 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 1,156 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 1,117 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 1,070 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 20 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 75
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-01-01 → 2022-12-31 | ¥30.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-12-31 | 11446 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-12-31 | ¥503.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-12-31 | ¥428.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥74.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-12-31 | ¥885.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-12-31 | ¥37.5bn |
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥12.7bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-12-31 | −¥79.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-12-31 | −¥79.9bn |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | −¥335.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥53.8bn |
| Japan Beer And Spiritsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥17.9bn |
| Japan Beer And Spiritsreportable segment | employees | at 2022-12-31 | 4275 pure |
| Japan Beer And Spiritsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥665.5bn |
| Japan Beer And Spiritsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥663.5bn |
| Japan Beer And Spiritsreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥2.0bn |
| Japan Beer And Spiritsreportable segment | segment assets | at 2022-12-31 | ¥432.1bn |
| Japan Beer And Spiritsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥74.7bn |
| Japan Non Alcoholic Beveragesreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥9.3bn |
| Japan Non Alcoholic Beveragesreportable segment | employees | at 2022-12-31 | 3467 pure |
| Japan Non Alcoholic Beveragesreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥245.8bn |
| Japan Non Alcoholic Beveragesreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥243.3bn |
| Japan Non Alcoholic Beveragesreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥2.5bn |
| Japan Non Alcoholic Beveragesreportable segment | segment assets | at 2022-12-31 | ¥133.2bn |
| Japan Non Alcoholic Beveragesreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥18.8bn |
| Oceaniareportable segment | capex | 2022-01-01 → 2022-12-31 | ¥13.1bn |
| Oceaniareportable segment | employees | at 2022-12-31 | 4049 pure |
| Oceaniareportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥256.0bn |
| Oceaniareportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥255.9bn |
| Oceaniareportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥91m |
| Oceaniareportable segment | segment assets | at 2022-12-31 | ¥546.7bn |
| Oceaniareportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥31.5bn |
| Pharmaceuticalsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥33.3bn |
| Pharmaceuticalsreportable segment | employees | at 2022-12-31 | 5982 pure |
| Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥398.4bn |
| Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥397.9bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-12-31 | ¥507m |
| Pharmaceuticalsreportable segment | segment assets | at 2022-12-31 | ¥880.3bn |
| Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥82.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-01-01 → 2021-12-31 | ¥26.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-12-31 | ¥418.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-12-31 | ¥347.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥70.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-12-31 | ¥859.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-12-31 | ¥31.3bn |
| Reconciling Itemsreconciling | capex | 2021-01-01 → 2021-12-31 | ¥18.5bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-12-31 | −¥74.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-12-31 | −¥74.9bn |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | −¥297.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥45.3bn |
| Japan Beer And Spiritsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥24.7bn |
| Japan Beer And Spiritsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥663.1bn |
| Japan Beer And Spiritsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥661.3bn |
| Japan Beer And Spiritsreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥1.8bn |
| Japan Beer And Spiritsreportable segment | segment assets | at 2021-12-31 | ¥432.8bn |
| Japan Beer And Spiritsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥70.5bn |
| Japan Non Alcoholic Beveragesreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥7.2bn |
| Japan Non Alcoholic Beveragesreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥246.6bn |
| Japan Non Alcoholic Beveragesreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥244.4bn |
| Japan Non Alcoholic Beveragesreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥2.2bn |
| Japan Non Alcoholic Beveragesreportable segment | segment assets | at 2021-12-31 | ¥139.2bn |
| Japan Non Alcoholic Beveragesreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥21.1bn |
| Oceaniareportable segment | capex | 2021-01-01 → 2021-12-31 | ¥13.3bn |
| Oceaniareportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥216.3bn |
| Oceaniareportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥216.3bn |
| Oceaniareportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥55m |
| Oceaniareportable segment | segment assets | at 2021-12-31 | ¥475.9bn |
| Oceaniareportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥26.6bn |
| Pharmaceuticalsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥29.3bn |
| Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥352.2bn |
| Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥351.7bn |
| Pharmaceuticalsreportable segment | revenue intersegment | 2021-01-01 → 2021-12-31 | ¥550m |
| Pharmaceuticalsreportable segment | segment assets | at 2021-12-31 | ¥862.1bn |
| Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥61.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,317
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | Prior4YearInstant_NonConsolidatedMember | 20 | |
| Number of employees | Prior3YearInstant_NonConsolidatedMember | 1070 | |
| Number of employees | Prior2YearInstant_NonConsolidatedMember | 1117 | |
| Number of employees | Prior1YearInstant_NonConsolidatedMember | 1156 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 914 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.827 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 0.882 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 0.920 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 0.736 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 0.819 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 0.840 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.992 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.066 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.202 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.172 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00395-000JapanBeerAndSpiritsReportableSegmentMember | 4275 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E00395-000JapanBeerAndSpiritsReportableSegmentMember | 855 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00395-000JapanNonAlcoholicBeveragesReportableSegmentMember | 3467 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E00395-000JapanNonAlcoholicBeveragesReportableSegmentMember | 562 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00395-000OceaniaReportableSegmentMember | 4049 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E00395-000OceaniaReportableSegmentMember | 469 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E00395-000PharmaceuticalsReportableSegmentMember | 5982 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E00395-000PharmaceuticalsReportableSegmentMember | 214 | |
| Number of employees | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 11446 | |
| Average number of temporary workers | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1912 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 1319 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | - | |
| Number of employees | CurrentYearInstant | 30538 | |
| Average number of temporary workers | CurrentYearInstant | 4012 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 914 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 42.49 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 15.0 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 9426260 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration | 74300000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00395-000JapanBeerAndSpiritsReportableSegmentMember | 800000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00395-000JapanNonAlcoholicBeveragesReportableSegmentMember | 800000000 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00395-000OceaniaReportableSegmentMember | 0 | JPY |
| Research and development expenses research and development activities | CurrentYearDuration_jpcrp030000-asr_E00395-000PharmaceuticalsReportableSegmentMember | 62400000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 93722000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00395-000JapanBeerAndSpiritsReportableSegmentMember | 17486000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00395-000JapanNonAlcoholicBeveragesReportableSegmentMember | 9142000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00395-000OceaniaReportableSegmentMember | 12554000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E00395-000PharmaceuticalsReportableSegmentMember | 20007000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 914000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 914000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 914000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 914000000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | 4 | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 170 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |